LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

Search

Phibro Animal Health Corp

Open

SectorHealthcare

21.6 10.43

Overview

Share price change

24h

Current

Min

18.95

Max

22.16

Key metrics

By Trading Economics

Income

-3.8M

3.2M

Sales

49M

309M

P/E

Sector Avg

38.396

54.379

EPS

0.54

Dividend yield

2.67

Profit margin

1.03

Employees

1,940

EBITDA

-4.9M

26M

Recommendations

By TipRanks

Recommendations

Sell

12 Months Forecast

+0.57% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.67%

2.55%

Next Dividend date

25 cze 2025

Next Ex Dividend date

4 cze 2025

Market Stats

By TradingEconomics

Market Cap

748M

Previous open

11.17

Previous close

21.6

News Sentiment

By Acuity

13%

87%

12 / 382 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Phibro Animal Health Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 maj 2025, 23:31 UTC

Earnings

DBS Group 1Q Net Fell on Higher Tax Expense

7 maj 2025, 22:40 UTC

Acquisitions, Mergers, Takeovers

ExxonMobil Signs Deal to Supply Low-Carbon Ammonia to Marubeni Corp.

7 maj 2025, 22:13 UTC

Earnings

ANZ Lifts First-Half Profit 7% as Long-Standing CEO Departs

7 maj 2025, 23:51 UTC

Market Talk

Nikkei May Trade Rangebound; Earnings in Focus -- Market Talk

7 maj 2025, 23:47 UTC

Market Talk

Gold Gains After Fed's Warning of Uncertainty to Economy From Tariffs -- Market Talk

7 maj 2025, 23:43 UTC

Acquisitions, Mergers, Takeovers

NTT: To Promptly Make an Announcement If, When It Becomes Necessary

7 maj 2025, 23:41 UTC

Top News

The Fed's Next Move Depends on Tariffs. It Could Take a While. -- Barrons.com

7 maj 2025, 23:41 UTC

Acquisitions, Mergers, Takeovers

Nippon Telegraph & Telephone: Board to Discuss Plan to Make NTT Data Group a Wholly Owned Unit on Thursday

7 maj 2025, 23:09 UTC

Earnings

Kakao 1Q Net Profit Beat FactSet-Compiled Consensus

7 maj 2025, 23:08 UTC

Earnings

Kakao 1Q Net KRW190.93B Vs. Net KRW67.68B >035720.SE

7 maj 2025, 23:08 UTC

Earnings

Kakao 1Q Oper Pft KRW105.40B Vs. Pft KRW120.29B >035720.SE

7 maj 2025, 23:08 UTC

Earnings

Kakao 1Q Rev KRW1.864T Vs. KRW1.988T >035720.SE

7 maj 2025, 23:03 UTC

Earnings

DBS Group Declares 1Q Dividend of S$0.60 >D05.SG

7 maj 2025, 23:02 UTC

Earnings

DBS Group 1Q Net Fee & Commission Income S$1.28B Vs. S$1.04B >D05.SG

7 maj 2025, 23:02 UTC

Earnings

DBS Group 1Q Net Interest Income S$3.72B Vs. S$3.65B >D05.SG

7 maj 2025, 23:02 UTC

Earnings

DBS Group 1Q Total Income S$5.91B Vs. S$5.56B >D05.SG

7 maj 2025, 23:01 UTC

Earnings

DBS Group 1Q Net S$2.90B Vs. Net S$2.96B >D05.SG

7 maj 2025, 22:22 UTC

Market Talk

PIMCO Expects Fed Still Points To Rate Cuts From September -- Market Talk

7 maj 2025, 22:10 UTC

Market Talk
Earnings

Clean Energy Shift Keeps 'Apace' Despite U.S. Uncertainties: TPG -- Market Talk

7 maj 2025, 22:00 UTC

Acquisitions, Mergers, Takeovers

Permian Resources to Buy APA's Northern Delaware Basin Assets for $608M

7 maj 2025, 21:50 UTC

Earnings

Nutrien: Expect U.S. Crop Input Demand Supported by Acreage Shifts in 2025, Corn Planted Expected to Increase to Approximately 95M Acres, Soybean Plantings to Decline to Approximately 83M Acres >NTR.T

7 maj 2025, 21:50 UTC

Earnings

Nutrien: Fertilizer Application Rates in the 2Q Have Been Strong as Farmers Focus on Maximizing Yield Potential >NTR.T

7 maj 2025, 21:50 UTC

Earnings

Nutrien 1Q Sales $5.1B >NTR.T

7 maj 2025, 21:50 UTC

Earnings

Nutrien 1Q EPS 2c >NTR.T

7 maj 2025, 21:49 UTC

Earnings

ANZ 1H Customer Deposits A$756.6M Vs. A$641.1M>ANZ.AU

7 maj 2025, 21:49 UTC

Earnings

ANZ 1H Net Loans and Advances A$820.2M Vs. A$715.2M>ANZ.AU

7 maj 2025, 21:43 UTC

Earnings

ANZ CEO: Bank's Diversified Business Is a Key Strength>ANZ.AU

7 maj 2025, 21:43 UTC

Earnings

ANZ CEO: Households Generally Remain Remarkably Robust, Resilient>ANZ.AU

7 maj 2025, 21:42 UTC

Earnings

ANZ CEO: Many Retail, Commercial Customers Continue to Face Challenges>ANZ.AU

7 maj 2025, 21:41 UTC

Earnings

ANZ CEO: Bank Is Well Positioned for Opportunities From Volatility>ANZ.AU

Peer Comparison

Price change

Phibro Animal Health Corp Forecast

Price Target

By TipRanks

0.57% upside

12 Months Forecast

Average 19.5 USD  0.57%

High 21 USD

Low 18 USD

Based on 2 Wall Street analysts offering 12 month price targets forPhibro Animal Health Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

2 ratings

0

Buy

1

Hold

1

Sell

Technical Score

By Trading Central

15 / 17Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

12 / 382 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.